Wutah dodolan YoY sajrone 12 wulan kepungkur: Minerva (NERV)

Logo grafis Minerva Neurosciences (NERV)

Sales dynamics based on the rolling 12-month year-over-year growth rate are tied to the FDA approval of roluperidone. The model relies on full outsourcing of production and testing, while patent protection creates a significant barrier to entry. Meanwhile, 0.00 records a new level, visualizing the market consensus regarding the revenue expansion rates of Minerva Neurosciences (NERV).

Wutah pendapatan YoY sajrone 12 wulan kepungkur Minerva Neurosciences, Inc. (NERV): kanggo periode 11.02.2024 - 16.11.2026

Ringkesan rincian data analitis Minerva (NERV)

Analisis kabeh metrik perusahaan:NERV Minerva Neurosciences Corp
Produk merek Minerva Neurosciences Corp

Effective asset selection requires a rigorous analysis of revenue dynamics to assess business viability. This indicator measures the daily change in aggregate revenues over a rolling year, reflecting the actual pace of commercial development. For Minerva Neurosciences (NERV), amid regulatory risks and tightening liquidity, this parameter becomes a critical marker of survival. The current value of 0.00 confirms a stage of financial instability. Evaluate the LTM annual sales growth rate as a signal of the issuer's potential resource depletion.

Karo sapa Minerva Neurosciences saingan

Wutah pendapatan taunan sajrone rolas wulan kepungkur Biogen Idec (BIIB)|NBIX - Wutah dodolan YoY sajrone rolas wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur RGC (Regencell Bioscience)|AXSM: Wutah dodolan YoY (TTM)|ACADIA Pharma (ACAD) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur Xenon Corp|VKTX: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) SUPN|Wutah dodolan YoY (TTM) catalystpharma.com (CPRX)|Wutah dodolan YoY sajrone rolas wulan kepungkur Denali Therapeutics DNLI|HRMY - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Biohaven Pharmaceutical - Wutah dodolan YoY (TTM)|Amylyx (AMLX) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|TRVI (Trevi Pharma) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku praxismedicines.com (PRAX)|AVXL (Anavex Life Sciences Corp) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur CBLL|Wutah pendapatan YoY sajrone 12 wulan kepungkur PRTA (prothena.com)|Alector - Wutah dodolan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY (TTM) ANNX (Annexon Biosciences)|OMER: Wutah dodolan YoY sajrone 12 wulan kepungkur|NGNE - Wutah dodolan YoY sajrone rolas wulan kepungkur|ACIU - Wutah dodolan YoY (TTM)|Voyager Corp (VYGR) - Wutah dodolan YoY sajrone rolas wulan kepungkur|NMRA - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Scilex|TVGN (Tevogen Bio) - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur ACOG (alphacognition.com)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Cognition Therapeutics, Inc.|Wutah dodolan YoY (TTM) IKT (Inhibikase Pharma)|Wutah dodolan YoY (TTM) Cassava Sciences, Inc. SAVA|ASRT - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Coya Therapeutics Inc|Vistagen Therapeutics (VTGN) - Wutah dodolan YoY sajrone rolas wulan kepungkur|OVID - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Acumen Pharmaceuticals, Inc|Wutah dodolan YoY sajrone rolas wulan kepungkur CRVO|Wutah dodolan YoY (TTM) ATHE|Clene - Wutah dodolan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY (TTM) PEPG (pepgen.com)|JUNS: Wutah dodolan YoY sajrone 12 wulan kepungkur|RLMD - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Annovis Bio, Inc.|GRCE (Grace Therapeutics) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Firefly Neuroscience (AIFF)|Wutah pendapatan YoY sajrone 12 wulan kepungkur KLTO|NRSN: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Reviva Pharmaceuticals Holdings (RVPH)|Wutah pendapatan YoY sajrone 12 wulan kepungkur MetaVia, Inc. MTVA|Wutah dodolan YoY sajrone rolas wulan kepungkur NeurAxis NRXS|HSDT: Wutah dodolan YoY sajrone 12 wulan kepungkur|passagebio.com - Wutah dodolan YoY (TTM)|NEUP - Wutah dodolan YoY (TTM)|Athira Pharma (ATHA) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Addex Therapeutics, Ltd. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|ALZN (Alzamend Neuro) - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku cyclerion.com CYCN|Wutah dodolan YoY (TTM) PTIX|KTTA - Wutah pendapatan taun lumaku|Wutah dodolan YoY (TTM) CRGT (Cortigent, Inc.)|Avenue Therapeutics Inc (ATXI) - Wutah pendapatan taun lumaku|BCLI - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku caratherapeutics.com|CHRO: Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Eliem Therapeutics (ELYM)|ITCI (Intra-Cellular Therapies Inc.) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY (TTM) Longboard|Wutah dodolan YoY (TTM) MRNS|Wutah pendapatan taunan sajrone rolas wulan kepungkur nkgenbiotech.com|Wutah dodolan YoY (TTM) NRBO (neurobopharma.com)|Sage Therapeutics, Inc (SAGE) - Wutah pendapatan taun lumaku|SNPX - Wutah dodolan YoY sajrone rolas wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur TRVN (Trevena, Inc)|VIGL: Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku anewmeds.com (WENA)|Wutah pendapatan YoY sajrone 12 wulan kepungkur CERE